Lowering the High Medical Cost of Substance Use Disorders - BrokerBank Securities, Inc.
NEW YORK, May 12, 2015 /PRNewswire/ -- Analyst report issued by Small Cap IR. Catasys, Inc. is an exciting early stage healthcare service company that is helping providers significantly lower the high cost of members with substance use disorders. The company has shown strong growth with an expanding list of blue chip clients with its unique OnTrak program which helps treat substance abuse with 52-week outpatient program that integrates evidence based medical and psychosocial interventions with care coaching.
Chardan Capital Markets recently issued a $6 price target on Catasys. Follow the link here to view price target. http://bit.ly/1RzKZ2x
An full analyst report on CATS that includes a brief company overview, technology solutions, financial review, analyst summary and recommendation can be viewed by using the following link at no cost.
http://bit.ly/-CATS-AnalystReport
Copy and paste to browser may be required.
This report was prepared for informational purposes only. Affiliated parties involved with producing and issuing this report have not been compensated in any form by profiled company. A full disclaimer can be found by viewing the full analyst report.
FORWARD-LOOKING DISCLAIMER
This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is written a 3rd party research analyst. However, we are only human and may make mistakes. If you notice any errors or omissions, please notify us below. We do not engage in high frequency trading.
BrokerBank Securities, Inc. is a member of the Financial Industry Regulatory Authority, CRD number #130116.
SOURCE BrokerBank Securities, Inc.
Related Links
http://www.brokerbanksecurities.com
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article